{"id":491048,"date":"2021-05-11T07:34:17","date_gmt":"2021-05-11T11:34:17","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/"},"modified":"2021-05-11T07:34:17","modified_gmt":"2021-05-11T11:34:17","slug":"miravo-healthcare-to-present-at-q2-virtual-investor-summit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/","title":{"rendered":"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit"},"content":{"rendered":"
\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n – <\/i>
\n
\n Tuesday, May 18<\/span>
\n th <\/sup>\u2013 2:00 p.m. ET<\/span><\/i>–<\/p>\n

\n MISSISSAUGA, ON<\/span>, May 11, 2021<\/span> \/PRNewswire\/ – Nuvo Pharmaceuticals\u00ae<\/sup> Inc. (TSX: MRV) (OTCQX: MRVFF) d\/b\/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger<\/span>, Miravo’s President & Chief Executive Officer and Mary-Jane Burkett<\/span>, Miravo’s Vice President & Chief Financial Officer will be presenting at the Q2 Virtual Investor Summit.\u00a0 <\/p>\n

\n

\n
\n \"Miravo
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n\n\n\n\n
\n

\n
\n DATE:\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n Tuesday, May 18,, <\/sup>2021<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n TIME:\u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n 2:00 p.m. ET<\/span>\n <\/p>\n<\/td>\n<\/tr>\n

\n

\n
\n COMPLIMENTARY
\u00a0REGISTRATION:<\/b>
\n \u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n

\n

\n
\n https:\/\/zoom.us\/webinar\/register\/WN_KHDIM1GmQi6On6OA6gAZ6w<\/a>
\n \u00a0<\/b>
\n <\/span>\n <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n

\n About The Investor Summit
<\/b>The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. \u00a0The Q2 Investor Summit will take place virtually, featuring 80+ companies and over 300 institutional and retail investors.\u00a0
Please visit the website at www.investorsummitgroup.com<\/a><\/p>\n

\n About Miravo Healthcare
<\/b>Miravo is a Canadian focused, healthcare company with global reach and a diversified portfolio of commercial products.\u00a0 The Company’s products target several therapeutic areas, including pain, allergy, neurology and dermatology.\u00a0 The Company’s strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.\u00a0 Miravo’s head office is located in Mississauga, Ontario, Canada<\/span>, the international operations are located in Dublin, Ireland<\/span> and the Company’s manufacturing facility is located in Varennes<\/span>, Qu\u00e9bec, Canada.\u00a0 The Varennes<\/span> facility operates in a Good Manufacturing Practices (GMP) environment respecting the U.S, Canada<\/span> and E.U. GMP regulations and is regularly inspected by Health Canada and the U.S. Food and Drug Administration.\u00a0 For additional information, please visit www.miravohealthcare.com<\/a>.<\/p>\n

<\/div>\n

\n \"Cision\" View original content to download multimedia:http:\/\/www.prnewswire.com\/news-releases\/miravo-healthcare-to-present-at-q2-virtual-investor-summit-301288267.html<\/a><\/p>\n

SOURCE Nuvo Pharmaceuticals Inc.<\/p>\n<\/p><\/div>\n

\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

PR Newswire – Tuesday, May 18 th \u2013 2:00 p.m. ET– MISSISSAUGA, ON, May 11, 2021 \/PRNewswire\/ – Nuvo Pharmaceuticals\u00ae Inc. (TSX: MRV) (OTCQX: MRVFF) d\/b\/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Miravo’s President & Chief Executive Officer and Mary-Jane Burkett, Miravo’s Vice President & Chief Financial Officer will be presenting at the Q2 Virtual Investor Summit.\u00a0 DATE:\u00a0 Tuesday, May 18,, 2021 TIME:\u00a0 2:00 p.m. ET COMPLIMENTARY\u00a0REGISTRATION: \u00a0 https:\/\/zoom.us\/webinar\/register\/WN_KHDIM1GmQi6On6OA6gAZ6w \u00a0 About The Investor SummitThe Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. \u00a0The Q2 Investor Summit will take place … <\/p>\n

Continue reading “Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-491048","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nMiravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire – Tuesday, May 18 th \u2013 2:00 p.m. ET– MISSISSAUGA, ON, May 11, 2021 \/PRNewswire\/ – Nuvo Pharmaceuticals\u00ae Inc. (TSX: MRV) (OTCQX: MRVFF) d\/b\/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Miravo’s President & Chief Executive Officer and Mary-Jane Burkett, Miravo’s Vice President & Chief Financial Officer will be presenting at the Q2 Virtual Investor Summit.\u00a0 DATE:\u00a0 Tuesday, May 18,, 2021 TIME:\u00a0 2:00 p.m. ET COMPLIMENTARY\u00a0REGISTRATION: \u00a0 https:\/\/zoom.us\/webinar\/register\/WN_KHDIM1GmQi6On6OA6gAZ6w \u00a0 About The Investor SummitThe Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. \u00a0The Q2 Investor Summit will take place … Continue reading "Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-11T11:34:17+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/1507300\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit\",\"datePublished\":\"2021-05-11T11:34:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/\"},\"wordCount\":294,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1507300\\\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/\",\"name\":\"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1507300\\\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg\",\"datePublished\":\"2021-05-11T11:34:17+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1507300\\\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/1507300\\\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/","og_locale":"en_US","og_type":"article","og_title":"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit - Market Newsdesk","og_description":"PR Newswire – Tuesday, May 18 th \u2013 2:00 p.m. ET– MISSISSAUGA, ON, May 11, 2021 \/PRNewswire\/ – Nuvo Pharmaceuticals\u00ae Inc. (TSX: MRV) (OTCQX: MRVFF) d\/b\/a Miravo Healthcare (Miravo or the Company), a Canadian focused healthcare company with global reach and a diversified portfolio of commercial products, today announced Jesse Ledger, Miravo’s President & Chief Executive Officer and Mary-Jane Burkett, Miravo’s Vice President & Chief Financial Officer will be presenting at the Q2 Virtual Investor Summit.\u00a0 DATE:\u00a0 Tuesday, May 18,, 2021 TIME:\u00a0 2:00 p.m. ET COMPLIMENTARY\u00a0REGISTRATION: \u00a0 https:\/\/zoom.us\/webinar\/register\/WN_KHDIM1GmQi6On6OA6gAZ6w \u00a0 About The Investor SummitThe Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. \u00a0The Q2 Investor Summit will take place … Continue reading \"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-05-11T11:34:17+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/1507300\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit","datePublished":"2021-05-11T11:34:17+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/"},"wordCount":294,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1507300\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/","name":"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/1507300\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg","datePublished":"2021-05-11T11:34:17+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/1507300\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/1507300\/Nuvo_Pharmaceuticals_Inc__Miravo_Healthcare__to_Present_at_Q2_Vi.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/miravo-healthcare-to-present-at-q2-virtual-investor-summit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Miravo Healthcare\u2122 to Present at Q2 Virtual Investor Summit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/491048","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=491048"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/491048\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=491048"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=491048"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=491048"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}